Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New therapeutic approach to persistent asthma.

C M Sanguinetti1

  • 1Unità Operativa di Pneumologia, Ospedale SS. Benvenuto e Rocco, Via Leopardi 15, 60027 Osimo, Ancona, Italy.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|February 24, 2001
PubMed
Summary

New combination inhalers for asthma combine inhaled corticosteroids and long-acting beta 2-agonists. This approach improves asthma control and patient compliance, offering a convenient and cost-effective treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical and integrated management of COPD.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2014
Same author

Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study).

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2010
Same author

GOLD severity stratification and risk of hospitalisation for COPD exacerbations.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2009
Same author

Nocturnal oxygen desaturation correlates with glycemia levels in patients with coronary artery disease.

Minerva cardioangiologica·2008
Same author

GP management of community-acquired pneumonia in Italy: the ISOCAP study.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2005
Same author

Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.

Pulmonary pharmacology & therapeutics·2004

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Asthma treatment goals have shifted from symptom relief to comprehensive disease control.
  • Current guidelines recommend inhaled corticosteroids (ICS) as first-line therapy for mild persistent asthma.
  • When ICS alone is insufficient, adding a long-acting beta 2-agonist (LABA) is more effective than increasing ICS dosage.

Purpose of the Study:

  • To evaluate the efficacy and benefits of fixed-dose combination inhalers for asthma management.
  • To highlight the advantages of combining ICS and LABA in a single formulation.

Main Methods:

  • Review of recent clinical trial data on fixed-combination inhalers.
  • Analysis of therapeutic activity and patient compliance with combined ICS/LABA therapy.

Main Results:

Related Experiment Videos

  • Fixed-dose combinations of salmeterol (LABA) and fluticasone propionate (ICS) improve asthma control in moderate-to-severe cases.
  • Combined inhalers enhance patient compliance due to the convenience of a single device.
  • Available in multiple ICS dosages, offering flexibility for varying asthma severity.
  • Combination inhalers present cost savings compared to separate medications.

Conclusions:

  • Fixed-dose ICS/LABA combination inhalers represent a significant advancement in asthma management.
  • These combination products offer improved disease control, better compliance, and cost-effectiveness.
  • The combination is anticipated to be widely adopted by both patients and healthcare providers.